BioLargo, Inc. Filing Effectiveness Notified

Ticker: BLGO · Form: EFFECT · Filed: Apr 16, 2026 · CIK: 0000880242

Sentiment: neutral

Topics: filing-effectiveness, sec-filing, procedural

Related Tickers: BLGO

TL;DR

BioLargo (BLGO) filing is now EFFECTIVE as of 4/15/26. Watch for next steps.

AI Summary

BioLargo, Inc. filed an EFFECT form on April 16, 2026, indicating the effectiveness of a filing related to Act 33, File No. 333-294948. The company's mailing and business address is 14921 Chestnut St., Westminster, CA 92683, with a contact number of 888 400-2863. BioLargo, Inc. is incorporated in Delaware and operates in the Chemicals & Allied Products sector.

Why It Matters

This filing signifies that a previous submission by BioLargo, Inc. has met SEC requirements and is now officially effective, potentially paving the way for new corporate actions or disclosures.

Risk Assessment

Risk Level: low — This is a procedural filing indicating effectiveness, not a direct financial event or negative news.

Key Numbers

Key Players & Entities

FAQ

What specific action or registration does this EFFECT filing pertain to for BioLargo, Inc.?

The filing is an 'EFFECT' form, which signifies the effectiveness of a prior submission, specifically related to Act 33 and File No. 333-294948, but the exact nature of the underlying action is not detailed in this notice.

When was this filing accepted by the SEC?

This filing was accepted by the SEC on April 16, 2026.

What is BioLargo, Inc.'s primary business sector according to the filing?

BioLargo, Inc. is listed under SIC code 2800, which corresponds to Chemicals & Allied Products.

Where is BioLargo, Inc. located?

BioLargo, Inc.'s mailing and business address is 14921 Chestnut St., Westminster, CA 92683.

What is the CIK number for BioLargo, Inc.?

The CIK number for BioLargo, Inc. is 0000880242.

Filing Details

This Form EFFECT (Form EFFECT) was filed with the SEC on April 16, 2026 regarding BIOLARGO, INC. (BLGO).

View full filing on EDGAR

View Full Filing

View this EFFECT filing on SEC EDGAR

View on Read The Filing